Full Text
ESTIMATED ECONOMIC AND CLINICAL IMPACTS OF ELIMINATING OTC ACCESS TO EXTRA-STRENGTH ACETAMINOPHEN

Abstract

Authors

B.G. Leinwand

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×